Literature DB >> 1333397

Growth behavior of human pancreatic carcinoma xenograft correlates with nuclear features.

H Coen1, H Kint, C F Kuyper, G N Jonges, N Dumarey, M Pauwels, G Kloppel, F Roels.   

Abstract

Two human pancreatic ductal adenocarcinomas with different growth rates were serially transplanted into nude mice. Feulgen-stained 4 microns sections and imprints from the xenografts were studied with a VICOM automated image analysis system. After pooling the results from two passages, with three mice in each passage, it was shown that of 23 nuclear parameters measured the following were correlated with a fast tumor growth rate: in sections, a decrease in heterogeneity of the chromatin and an increase in perimeter and nuclear area; in imprints, an increase in lesser diameter, in mean grey level difference between second neighboring pixels, and in total integrated optical density (DNA content). Several parameters differed significantly between passages, and between animals in the same passage. These findings suggest that the growth speed of pancreatic tumors may be predicted by nuclear parameters.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333397     DOI: 10.1002/cyto.990130714

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  3 in total

1.  Ectopic mineralized cartilage formation in human undifferentiated pancreatic adenocarcinoma explants grown in nude mice.

Authors:  C J Van Noorden; G N Jonges; I M Vogels; K A Hoeben; B Van Urk; V Everts
Journal:  Calcif Tissue Int       Date:  1995-02       Impact factor: 4.333

2.  Vinblastine and 5-fluorouracil sensitivity of xenografts of four pancreatic ductal adenocarcinomas: is there a correlation with histological and cytological tumour differentiation?

Authors:  A Vergeylen; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants.

Authors:  C J Van Noorden; T G Jonges; L C Meade-Tollin; R E Smith; A Koehler
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.